USPTO
US Appeals Court Reverses Patent Office Decision That Blocked Snipr Biome CRISPR IP
The appeals court found that the US Patent Trial and Appeal Board had erred in subjecting Snipr's patents to an interference, which was eliminated under a recent patent law change.
USPTO Rules in Favor of Broad Institute in CRISPR/Cas9 IP Dispute
The Broad's CRISPR/Cas9 patents were found to have priority over similar IP from the University of California and others.
Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable
This week, the US PTAB found that some claims of a Personal Genomics patent for single-molecule detection didn't hold up, while others remain valid.
US Appeals Court Upholds Invalidation of Columbia University Sequencing Chemistry Patents
The appellate court's decision deals a blow to a 2017 Columbia University lawsuit that alleged Illumina infringed one of the invalidated patents.
Rakuten Medical Sues Illumina Over Trademark Dispute
The cancer therapy developer has asked a US federal court to declare that its Illuminox platform does not infringe Illumina's trademarks.
Oct 28, 2016
Jun 1, 2016
Illumina Sues Qiagen for Patent Infringement
Oct 30, 2014
Oct 16, 2014
Sep 25, 2014
Aug 27, 2014
Aug 14, 2014
Aug 7, 2014
Jul 31, 2014